Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "US PA Philadelphia Falk MJ"

From Bioblast
Line 14: Line 14:
|MiPNetLab=Polyak E
|MiPNetLab=Polyak E
|Status=O2k 2008-
|Status=O2k 2008-
|info=[http://www.oroboros.at/?IOC47 IOC47]
|keyword=Respiratory OXPHOS disease
|keyword=Respiratory OXPHOS disease
}}
}}
Line 19: Line 20:


* ''We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents.'' [[Falk MJ]]
* ''We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents.'' [[Falk MJ]]
== Participated at ==
* IOC47

Revision as of 06:20, 18 February 2014

Template:MiPNetLab

  • We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents. Falk MJ